PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
9.15%
Revenue growth similar to 3391.T's 8.88%. Walter Schloss would see if both companies share industry tailwinds.
5.86%
Gross profit growth at 75-90% of 3391.T's 7.46%. Bill Ackman would demand operational improvements to match competitor gains.
12.81%
EBIT growth below 50% of 3391.T's 82.25%. Michael Burry would suspect deeper competitive or cost structure issues.
12.93%
Operating income growth under 50% of 3391.T's 79.59%. Michael Burry would be concerned about deeper cost or sales issues.
-13.39%
Negative net income growth while 3391.T stands at 133.19%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-13.40%
Negative EPS growth while 3391.T is at 133.20%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-13.40%
Negative diluted EPS growth while 3391.T is at 134.03%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
-2.38%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-2.38%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
157.75%
Similar 10Y revenue/share CAGR to 3391.T's 172.77%. Walter Schloss might see both firms benefiting from the same long-term demand.
57.39%
5Y revenue/share CAGR above 1.5x 3391.T's 35.00%. David Dodd would look for consistent product or market expansions fueling outperformance.
27.75%
3Y revenue/share CAGR above 1.5x 3391.T's 15.22%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
108.53%
Similar net income/share CAGR to 3391.T's 100.82%. Walter Schloss would see parallel tailwinds or expansions for both firms.
33.23%
5Y net income/share CAGR above 1.5x 3391.T's 13.61%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
-13.11%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
353.50%
10Y equity/share CAGR above 1.5x 3391.T's 152.29%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
90.72%
5Y equity/share CAGR above 1.5x 3391.T's 39.07%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
41.66%
3Y equity/share CAGR above 1.5x 3391.T's 11.76%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
9.07%
AR growth well above 3391.T's 4.21%. Michael Burry fears inflated revenue or higher default risk in the near future.
3.03%
Inventory growth well above 3391.T's 0.27%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
3.36%
Positive asset growth while 3391.T is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
2.00%
Positive BV/share change while 3391.T is negative. John Neff sees a clear edge over a competitor losing equity.
-33.66%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
83.99%
We expand SG&A while 3391.T cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.